Johns Hopkins Study: COVID-19 Vaccination in Patients with Chronic Conditions

Article Publication Date:

1/29/2021

Summary:

COVID-19 Antibody Testing of Patients with Chronic Conditions is being led by a team of researchers at Johns Hopkins Medicine. The purpose of the study is to determine the safety of the COVID-19 vaccine as well as COVID-19 antibody levels in patients who receive the vaccine with the following chronic conditions: HIV, an autoimmune condition, cirrhosis, or on home dialysis.

Article Author:

Johns Hopkins University

Topics:

Research study

COVID-19 Vaccines

High risk populations

Types/Tools:

Assessments

Populations:

immunocompromised patients

Sources:

Johns Hopkins University School of Medicine